Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GSK To Cut R&D Staff | Contract Pharma

What are you searching for?

Sign in
Breaking News

GSK To Cut R&D Staff

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline plans to cut 350 jobs, or 2% of its research staff, as part of an ongoing restructuring plan aimed at increasing productivity, according to a company statement.
   
“We continue to reshape our R&D operations to take advantage of new scientific opportunities and improve GSK’s productivity,” according to a company statement. “Regrettably some job reductions are necessary and we will do everything we can to support those employees who are affected.”
   
In October, the company announced plans to cut jobs and possibly close some sites as part of a $3.1 billion program to cut costs, increase R&D, and streamline manufacturing. The program is expected to save as much as $1.4 billion in costs by 2010.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics